Overall response
| Parameter . | N = 37 (%) . |
|---|---|
| Median no. cycles received [range] | 3 [1-18] |
| Median follow-up in weeks [range] | 24 [5-71] |
| Response | |
| CR | 6 (16) |
| Cri | 10 (27) |
| PR | 1* (3) |
| NR | 18 (49) |
| Died | 2 (5) |
| Median no. cycles to response [range] | 2 [1-7] |
| 4-wk mortality | 1 (3) |
| 8-wk mortality | 1 (3) |
| Parameter . | N = 37 (%) . |
|---|---|
| Median no. cycles received [range] | 3 [1-18] |
| Median follow-up in weeks [range] | 24 [5-71] |
| Response | |
| CR | 6 (16) |
| Cri | 10 (27) |
| PR | 1* (3) |
| NR | 18 (49) |
| Died | 2 (5) |
| Median no. cycles to response [range] | 2 [1-7] |
| 4-wk mortality | 1 (3) |
| 8-wk mortality | 1 (3) |
Patient’s BM blast percentage fell from 66% to 6% with normalization of peripheral counts.